Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
As liquid biopsy applications expand into earlier cancer detection and increasingly challenging clinical settings, assay performance has never been more critical. This session will explore how researchers and technology developers are improving assay sensitivity through advances in sequencing strategies, target enrichment and workflow optimisation. It will also examine how assay design decisions impact reproducibility, scalability and suitability for downstream use in translational research and clinical studies.